Beckman Coulter’s Alzheimer’s blood test obtains CE mark

Beckman Coulter's assay is used to measure phosphorylated tau (pTau217) levels in the blood of individuals displaying signs of cognitive decline. Beckman Coulter's assay is used to measure phosphorylated tau (pTau217) levels in the blood of individuals displaying signs of cognitive decline. Beckman’s blood test uses ALZpath’s pTau217 assay to which it signed a licensing agreement for the use of in July 2024. Credit: Sundry Photography/Shutterstock.com Beckman Coulter Diagnostics has secured a CE mark for a blood test to aid in the clinical evaluation of amyloid pathology under the European Union’s in vitro diagnostic regulation (EU IVDR). Using ALZpath’s pTau217…

Source: Medical Device Network